Morepen Laboratories Limited (NSE:MOREPENLAB)
53.29
-3.53 (-6.21%)
Jul 22, 2026, 3:29 PM IST
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 29.19 billion as of July 22, 2026. Its market cap has decreased by -13.97% in one year.
Market Cap
29.19B
Enterprise Value
30.36B
Revenue
18.06B
Ranking
n/a
PE Ratio
30.77
Stock Price
53.29
ChartMarket Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 29.19B, an increase of 237.14%. That is a compound annual growth rate of 4.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 29.19B | 29.71% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 63.67B |
| Innova Captab | 56.08B |
| Orchid Pharma | 51.89B |
| RPG Life Sciences | 49.58B |
| Solara Active Pharma Sciences | 26.92B |
| Beta Drugs | 25.02B |
| Indoco Remedies | 22.69B |
| Ind-Swift Laboratories | 20.60B |